SEBI has recently notified the SEBI (ICDR) (Fourth Amendment) Regulations, 2022. Through this amendment, SEBI introduced an optional alternative mechanism of “pre-filing” of offer document with SEBI in case of Initial Public Offer on the Main Board.
Under this mechanism, the DRHP (containing vital information about the company’s business and financials) is made available only to the regulator and not to the public at large. This would help companies to explore the IPO listing option without undergoing the public scrutiny. Withholding of sensitive information would also allay the apprehension of any undue advantage taken by the competitors of the issuer company (especially in the case of the new age growth companies).
Currently any issuer company, desirous of coming out with an IPO on the Main Board, is required to go through the following process:
Through the notified amendments, a new chapter IIA has been added to the SEBI (ICDR) Regulations, 2018. This chapter provides for an optional and alternative mechanism of filing offers documents.
Under this mechanism,
Sl. No. | Existing | Pre-filing | ||||
---|---|---|---|---|---|---|
1. | Filing of DRHP with SEBI. Document available in public domain. |
Filing of pre-filing draft offer document with SEBI. Document not available in public domain. |
||||
2. | Receipt of SEBI’s Observation Letter. | Receipt of SEBI’s Observation Letter. | ||||
3. | Filing of UDRHP (incorporating SEBI’s observations). Document not available in public domain. |
Filing of UDRHP-I(incorporating SEBI’s observations). Document available in public domain. |
||||
4. | Filing of UDRHP-II with SEBI (incorporating public comments) Document not available in public domain |
|||||
5. | IPO within 12 months from SEBI’s observation letter. | IPO within 18 months from SEBI’s observation letter. |
The amendments by SEBI would be beneficial for the companies to explore the option of listing without undergoing public scrutiny. Past records show that many companies have opted out of the IPO despite filing the DRHP. Moreover, the provisions of confidential filings are also available in foreign jurisdictions like US, UK and Canada.
Except for the marginal delay and additional cost, the optional route of confidential IPO filing does not have any other disadvantage. Moreover, the substantial benefits on account of withholding sensitive information and flexibility to choose the IPO timing far outweighs the marginal cost and time impacts.
•Laws are constantly changing, either
their substance or their interpretation. Even though every attempt is made to keep the information correct
and updated, yet if you find some information to be wrong or dated, kindly let us know. We will acknowledge
your contribution.Click here to know more.
•Disclaimer: This is not professional advice. Please read Terms of Use (more specifically clauses 3 and 4) for detailed disclaimer.